CLINICAL_TRIALS
trial_result
· 2021-12-06
Clinical Trial Update: Trial Comparing PLA to HIGRT (PROVE-HCC) [NA]
Summary
A terminated clinical trial (PROVE-HCC) comparing PLA to HIGRT in hepatocellular carcinoma with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Hepatocellular Carcinoma | NA | Status: TERMINATED | Results posted: 2021-12-06